Hana Pharm Co Ltd (293480) — Cash Flow Reinvestment Rate
Hana Pharm Co Ltd (293480) has a Cash Flow Reinvestment Rate of 45.12x as of June 2025, reinvesting ₩10.61 Billion (capex ₩10.01 Billion plus investments ₩-600.00 Million) from operating cash flow of ₩235.15 Million. Check 293480 cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Hana Pharm Co Ltd Cash Flow Reinvestment Rate (2016–2024)
Historical reinvestment intensity for Hana Pharm Co Ltd across 9 annual periods. Explore how much of Hana Pharm Co Ltd's assets are long-term investments to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Hana Pharm Co Ltd (2016–2024)
Year-by-year capital reinvestment analysis for Hana Pharm Co Ltd. For live market cap and broader valuation context, see 293480 stock market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.57x | ₩14.30 Billion | ₩25.30 Billion | ₩13.21 Billion | ▼ -60.9% |
| 2023 | 1.44x | ₩26.58 Billion | ₩18.40 Billion | ₩14.68 Billion | ▼ -38.3% |
| 2022 | 2.34x | ₩72.28 Billion | ₩30.88 Billion | ₩35.77 Billion | ▼ -14.6% |
| 2021 | 2.74x | ₩70.31 Billion | ₩25.66 Billion | ₩34.81 Billion | ▲ +137.4% |
| 2020 | 1.15x | ₩17.98 Billion | ₩15.58 Billion | ₩17.14 Billion | ▼ -30.7% |
| 2019 | 1.66x | ₩52.79 Billion | ₩31.72 Billion | ₩33.73 Billion | ▼ -55.6% |
| 2018 | 3.75x | ₩103.50 Billion | ₩27.59 Billion | ₩5.57 Billion | ▲ +691.2% |
| 2017 | 0.47x | ₩12.04 Billion | ₩25.38 Billion | ₩10.19 Billion | ▼ -36.3% |
| 2016 | 0.74x | ₩9.27 Billion | ₩12.46 Billion | ₩8.31 Billion | — |